Anti-Caspase-9 antibody [E23] - BSA and Azide free

8 product images

• 

  Western blot - Anti-Caspase-9 antibody [E23] - BSA and Azide free (ab219590)

  False colour image of Western blot: Anti-Caspase-9 antibody [E23] staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (Anti-Calnexin antibody [CANX/1543] ab238078) loading control staining at 1/20000 dilution, shown in red. In Western blot, Anti-Caspase-9 antibody [E23] ab32539 was shown to bind specifically to Caspase-9. A band was observed at 45 kDa in wild-type THP-1 cell lysates with no signal observed at this size in CASP9 knockout cell line Human CASP9 knockout THP-1 cell line ab276122 (knockout cell lysate ab284219). To generate this image, wild-type and CASP9 knockout THP-1 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween^® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye^® 800CW) preabsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye^® 680RD) preabsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) at 1/20000 dilution.

  All lanes: Western blot - Anti-Caspase-9 antibody [E23] (Anti-Caspase-9 antibody [E23] ab32539) at 1/1000 dilution

  Lane 1: Wild-type THP-1 cell lysate at 20 µg

  Lane 2: CASP9 knockout THP-1 cell lysate at 20 µg

  Lane 2: Western blot - Human CASP9 knockout THP-1 cell line (Human CASP9 knockout THP-1 cell line ab276122)

  Lane 3: HeLa cell lysate at 20 µg

  Performed under reducing conditions.

  Predicted band size: 46 kDa

  Observed band size: 45 kDa

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caspase-9 antibody [E23] - BSA and Azide free (ab219590)

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human skeletal muscle tissue labelling Caspase-9 with purified Anti-Caspase-9 antibody [E23] ab32539 at 1/250. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. Goat Anti-Rabbit IgG H&L (HRP) ab97051, a HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500). Negative control using PBS instead of primary antibody. Counterstained with hematoxylin.

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Caspase-9 antibody [E23] ab32539).

• 

  Immunoprecipitation - Anti-Caspase-9 antibody [E23] - BSA and Azide free (ab219590)

  Anti-Caspase-9 antibody [E23] ab32539 (purified) at 1/80 immunoprecipitating Caspase-9 in HeLa whole cell lysate.

  Lane 1 (input): HeLa whole cell lysate (10µg)

  Lane 2 (+): Anti-Caspase-9 antibody [E23] ab32539 + HeLa whole cell lysate.

  Lane 3 (-): Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of Anti-Caspase-9 antibody [E23] ab32539 in HeLa whole cell lysate.

  For western blotting, a HRP-conjugated anti-rabbit IgG, specific to the non-reduced form of IgG was used as the secondary antibody (1/1500).

  Blocking buffer and concentration: 5% NFDM/TBST.

  Diluting buffer and concentration: 5% NFDM /TBST.

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Caspase-9 antibody [E23] ab32539).

  All lanes: Immunoprecipitation - Anti-Caspase-9 antibody [E23] (Anti-Caspase-9 antibody [E23] ab32539)

  Predicted band size: 46 kDa

  Observed band size: 46 kDa

• 

  Immunocytochemistry/ Immunofluorescence - Anti-Caspase-9 antibody [E23] - BSA and Azide free (ab219590)

  Immunocytochemistry/Immunofluorescence analysis of HepG2 cells labelling Caspase-9 with purified Anti-Caspase-9 antibody [E23] ab32539 at 1/500. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077, an Alexa Fluor^® 488-conjugated goat anti-rabbit IgG (1/1000) was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain. Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291, a mouse anti-tubulin (1/1000) and Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) preadsorbed ab150120, an Alexa Fluor^® 594-conjugated goat anti-mouse IgG (1/1000) were also used.

  Control 1: primary antibody (1/500) and secondary antibody, Goat Anti-Mouse IgG H&L (Alexa Fluor® 594) preadsorbed ab150120, an Alexa Fluor^® 594-conjugated goat anti-mouse IgG (1/1000).

  Control 2: Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291 (1/1000) and secondary antibody, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077, an Alexa Fluor^® 488-conjugated goat anti-rabbit IgG (1/1000).

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Caspase-9 antibody [E23] ab32539).

• 

  Flow Cytometry (Intracellular) - Anti-Caspase-9 antibody [E23] - BSA and Azide free (ab219590)

  Intracellular Flow Cytometry analysis of K562 cells labelling Caspase-9 with purified Anti-Caspase-9 antibody [E23] ab32539 at 1/250 (red). Cells were fixed with 100% methanol. A FITC-conjugated goat anti-rabbit IgG (1/500) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Caspase-9 antibody [E23] ab32539).

• 

  Flow Cytometry (Intracellular) - Anti-Caspase-9 antibody [E23] - BSA and Azide free (ab219590)

  Overlay histogram showing K562 cells stained with unpurified Anti-Caspase-9 antibody [E23] ab32539 (red line). The cells were fixed with methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (unpurified Anti-Caspase-9 antibody [E23] ab32539, 1/100 dilution) for 30 min at 22°C. The secondary antibody used was anti-rabbit DyLight^® 488 (Goat Anti-Rabbit IgG H&L (DyLight® 488) preadsorbed ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit monoclonal IgG (1μg/1x10⁶ cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in K562 cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween used under the same conditions.
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Caspase-9 antibody [E23] ab32539).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Caspase-9 antibody [E23] - BSA and Azide free (ab219590)

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human cervical carcinoma tissue labelling Caspase 9 with unpurified Anti-Caspase-9 antibody [E23] ab32539 at a dilution of 1/50.
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Caspase-9 antibody [E23] ab32539).

  Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

• 

  Image collected and cropped by CiteAb under a CC-BY license from the publication

  Western blot - Anti-Caspase-9 antibody [E23] - BSA and Azide free (ab219590)

  Caspase-9 western blot using anti-Caspase-9 antibody [E23] - BSA and Azide free ab219590. Publication image and figure legend from Jiang, S., Zou, Z., et al., 2015, PLoS One, PubMed 26176608.

  
  

  ab219590 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab219590 please see the product overview.

  mTOR inhibitors combined with glycolysis inhibitor induced apoptosis in lung cancer cells.(a) A549 cells were pretreated with 5 mM 2DG for 1 h, and then cells were treated with 8 μM rapamycin or 5 μM AZD2014 for additional 48 h respectively, cell apoptosis was then examined by using an Annexin V-FITC/PI staining assay kit. (b) A549 cells were pretreated with 5 mM 2DG for 1 h, and then treated with 5 μM AZD2014 for additional 48 h, as well as the cells were untreated and treated with 5 mM 2-DG or 5 μM AZD2014 alone for 48 h before harvesting cellular proteins. (c) A549 cells were pretreated with 5 mM 2DG for 1 h, and then treated with 5 μM AZD2014 for additional 48 h. Meanwhile, the cells were untreated and treated with 5 mM 2DG or 5 μM AZD2014 alone for 48 h before harvesting cellular proteins. All cell lysates were probed for the apoptosis–associated proteins such as BAX, BCL-2, cleaved PARP, cleaved caspase-3 and caspase 9 by Western blot. The similar results were obtained from other two independent experiments, and data shown are the representatives of the three experiments.